fashion -WSS

fashion

author：focus 2025-10-01 02:27:32 - browse：5

A woman walks in San Francisco, with her father who has Alzheimer's – public health and science coverage from STAT — Ben Margot/AP

A host of hurdles are slowing the adoption of the new Alzheimer’s drug Leqembi, experts involved in the treatment of patients said Wednesday, from complicated logistics to the fact that many people don’t recognize that their memory loss is a disease soon enough.

Some patients still grapple with whether they want to be diagnosed, even though a treatment exists, the experts said, speaking during a STAT virtual event.

“Even the word for dementia does not always exist in every culture and in every language,” said Hollis Day, chief of geriatrics at Boston Medical Center and a professor at Boston University’s medical school. “And so just getting people to accept that memory loss is not normal aging necessarily, is a big barrier to getting people into diagnosis early enough to benefit from these treatments.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： DIEP, the 'gold standard' of breast reconstruction, is under threat
Next article： Intarcia’s device

hotspot

WSS

Dana Farber says 6 studies to be retracted and 31 corrected

Dog Aging Project founders on what lies ahead after losing funding

Second xenotransplant done with gene

FDA sets aggressive timeline for overhauling inspection procedures

CDC advisers recommend seasonal use of Pfizer RSV shot

Senators: Long

Wikipedia

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

Medicare proposal to cover medical devices draws a mixed reaction

Hearing on Medicare drug price negotiation gets unusually heated

Trump demands the U.S. pay no more for drugs than other countries … again

Head of FDA's diagnostics center, who led through Covid, retires

BioMarin wins approval for gene therapy to treat hemophilia A

Experts study whether long Covid risk adds up with each reinfection

At least 13 dead in Texas as scorching temps continue

CDC's new outbreak response network to include Northeastern

Walensky prepares to leave CDC — and Congress — behind

Senate HELP committee spars over health care workforce policies

focus

CVS is on a mission to consolidate health care. Will it work?

FDA panel to weigh approval of NurOwn, controversial ALS drug

Ukraine and a new approach to mental health in war

Medicare bonuses could stop drug shortages under Senate plan

Lasker Awards 2023: Winners in biomedical research

FDA endorses new sterilization method for medical devices

entertainment

hotspot

hotspot

leisure time